These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26505120)

  • 41. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective cohort trial to confirm the efficacy of no-touch radio frequency ablation.
    Hirooka M; Hiraoka A; Ochi H; Koizumi Y; Michitaka K; Joko K; Abe M; Hiasa Y
    J Gastroenterol Hepatol; 2019 Mar; 34(3):567-574. PubMed ID: 30225957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
    Luo HM; Zhao SZ; Li C; Chen LP
    Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis.
    Santambrogio R; Opocher E; Zuin M; Selmi C; Bertolini E; Costa M; Conti M; Montorsi M
    Ann Surg Oncol; 2009 Dec; 16(12):3289-98. PubMed ID: 19727960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
    Lee HW; Choi GH; Kim DY; Park YN; Kim KS; Choi JS; Ahn SH; Han KH
    Oncology; 2017; 93(4):224-232. PubMed ID: 28571030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma.
    Tanaka K; Shimada H; Matsumoto C; Matsuo K; Nagano Y; Endo I; Togo S
    Surgery; 2008 May; 143(5):607-15. PubMed ID: 18436008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
    Geissler EK; Schnitzbauer AA; Zülke C; Lamby PE; Proneth A; Duvoux C; Burra P; Jauch KW; Rentsch M; Ganten TM; Schmidt J; Settmacher U; Heise M; Rossi G; Cillo U; Kneteman N; Adam R; van Hoek B; Bachellier P; Wolf P; Rostaing L; Bechstein WO; Rizell M; Powell J; Hidalgo E; Gugenheim J; Wolters H; Brockmann J; Roy A; Mutzbauer I; Schlitt A; Beckebaum S; Graeb C; Nadalin S; Valente U; Turrión VS; Jamieson N; Scholz T; Colledan M; Fändrich F; Becker T; Söderdahl G; Chazouillères O; Mäkisalo H; Pageaux GP; Steininger R; Soliman T; de Jong KP; Pirenne J; Margreiter R; Pratschke J; Pinna AD; Hauss J; Schreiber S; Strasser S; Klempnauer J; Troisi RI; Bhoori S; Lerut J; Bilbao I; Klein CG; Königsrainer A; Mirza DF; Otto G; Mazzaferro V; Neuhaus P; Schlitt HJ
    Transplantation; 2016 Jan; 100(1):116-25. PubMed ID: 26555945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic factors influencing postoperative survival in patients with Wu FS; Zhao WH; Liang TB; Ren GP; Ma ZM; Teng LS
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):579-83. PubMed ID: 15938929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anatomic versus non-anatomic resection of hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Sun Z; Li Z; Shi XL; He XW; Chen J; Song JH
    Asian J Surg; 2021 Sep; 44(9):1143-1150. PubMed ID: 33766529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma.
    Cucchetti A; Cescon M; Ercolani G; Bigonzi E; Torzilli G; Pinna AD
    Ann Surg Oncol; 2012 Nov; 19(12):3697-705. PubMed ID: 22722807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
    Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
    Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
    Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.